Pharmaceutical composition for modified release
US-2024277675-A1 · Aug 22, 2024 · US
US9066902B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9066902-B2 |
| Application number | US-201013387489-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2010 |
| Priority date | Jul 31, 2009 |
| Publication date | Jun 30, 2015 |
| Grant date | Jun 30, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds of formula I and their metabolites are potent mediators of an inflammatory response: (I) where a, b, c, d, e, f, V, W, X, Y, R a , R a′ , R b , R b′ , R c , and R c′ are defined herein. In particular, the compounds of the invention are candidate therapeutics for treating inflammatory conditions.
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical formulation comprising: an effective amount of a compound having a formula of: wherein: R 1 is a heterocyclyl; is an optional double bond; W is —OH, —C(O)H, —C(O), —C(O)R p , —COOH, —COOR p , —Cl, —Br, —I, —CF 3 , —CN, —SO 3 , —SO 2 R p , —SO 3 H, —NH 3 + , —NH 2 R p+ , —NR p R q R t , —NO 2 , ═O, ═NR p…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.